Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Eric Q, Konnick"'
Autor:
Joel Yambert, Leigh A. Henricksen, June Clements, Andrew Hannon, Alyssa Jordan, Shalini Singh, Katerina Dvorak, Colin C. Pritchard, Eric Q. Konnick
Publikováno v:
Journal of Molecular Pathology, Vol 3, Iss 4, Pp 339-354 (2022)
Background and Aims: Multiple laboratory methods are used to screen patients with colorectal cancer (CRC) for mismatch repair (MMR) protein deficiency to identify possible Lynch syndrome patients. The goal of this study was to compare the agreement b
Externí odkaz:
https://doaj.org/article/7fd268f18b5b40ef9ff4f2f9eb7651fc
Autor:
C. Eric Freitag, Wei Chen, Rachel Pearlman, Heather Hampel, Peter P. Stanich, Casey M. Cosgrove, Eric Q. Konnick, Colin C. Pritchard, Wendy L. Frankel
Publikováno v:
Human Pathology. 137:1-9
Autor:
Eric Q. Konnick
Publikováno v:
Practical Laboratory Medicine, Vol 21, Iss , Pp e00172- (2020)
The regulatory landscape for precision oncology in the United States is complicated, with multiple governmental regulatory agencies with different scopes of jurisdiction. Several regulatory proposals have been introduced since the Food and Drug Admin
Externí odkaz:
https://doaj.org/article/b4e9795d8b964938995c8ccbfc8ee695
Autor:
Ayako J. Kuo, Vera A. Paulson, Jennifer A. Hempelmann, Mallory Beightol, Sheena Todhunter, Brice G. Colbert, Stephen J. Salipante, Eric Q. Konnick, Colin C. Pritchard, Christina M. Lockwood
Publikováno v:
Practical Laboratory Medicine, Vol 19, Iss , Pp - (2020)
Objectives: The rapid discovery of clinically significant genetic variants has translated to next-generation sequencing assays becoming out-of-date by the time they are designed, validated, and implemented. UW-OncoPlex addresses this through the adop
Externí odkaz:
https://doaj.org/article/c9d2733df5de49c1ab6b4390e50bce81
Autor:
Siobhan S. Pattwell, Eric Q. Konnick, Yajuan J. Liu, Rebecca A. Yoda, Laligam N. Sekhar, Patrick J. Cimino
Publikováno v:
Case Reports in Pathology, Vol 2020 (2020)
Pilocytic astrocytoma is a low-grade glial neoplasm of the central nervous system (CNS) that tends to occur in the pediatric population and less commonly presents in adults. Hereditary pilocytic astrocytoma is often associated with germline genetic a
Externí odkaz:
https://doaj.org/article/62c4dbf01dc149e0ae4df48e9d5b416b
Autor:
Jennifer A. Hempelmann, Christina M. Lockwood, Eric Q. Konnick, Michael T. Schweizer, Emmanuel S. Antonarakis, Tamara L. Lotan, Bruce Montgomery, Peter S. Nelson, Nola Klemfuss, Stephen J. Salipante, Colin C. Pritchard
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)
Abstract Background Microsatellite instability (MSI) is now being used as a sole biomarker to guide immunotherapy treatment for men with advanced prostate cancer. Yet current molecular diagnostic tests for MSI have not been evaluated for use in prost
Externí odkaz:
https://doaj.org/article/b188986515774b1cb558720c61fd6f1d
Publikováno v:
Clinics in Laboratory Medicine. 42:485-496
Autor:
Natasha Hunter, Lanell M. Peterson, Mark Muzi, Eric Q. Konnick, Jonathan Reichel, Paul Kinahan, Jennifer M. Specht, Rachel Yung, William R. Gwin, Hannah Linden, Christina Tran
Publikováno v:
Cancer Research. 83:P2-03
Background: 18F-FES is an FDA-approved estrogen analogue PET imaging tracer (Cerianna) which measures tumor estrogen receptor (ER) expression at multiple tumor sites simultaneously and predicts response to endocrine therapy. 18F-FDG is a commonly use
Autor:
Niklas Krumm, Nithisha S. Khasnavis, Marc Radke, Kalyan Banda, Helen R. Davies, Christopher Pennil, Kathryn McLean, Vera A. Paulson, Eric Q. Konnick, Winslow C. Johnson, Grogan Huff, Serena Nik-Zainal, Elizabeth M. Swisher, Christina M. Lockwood, Stephen J. Salipante
Publikováno v:
JCO Precision Oncology.
PURPOSE Homologous recombination DNA repair deficiency (HRD) is a therapeutic biomarker for sensitivity to platinum and poly(ADP-ribose) polymerase inhibitor therapies in breast and ovarian cancers. Several molecular phenotypes and diagnostic strateg
Autor:
Sanaz Nourmohammadi Abadchi, Laura A. Sena, Emmanuel S. Antonarakis, Colin C. Pritchard, James R. Eshleman, Eric Q. Konnick, Stephen J. Salipante, Eugene Shenderov, Tamara L. Lotan
Publikováno v:
JCO Precision Oncology.
PURPOSE Among mismatch repair-deficient (MMRd) prostate cancers, loss of MLH1 is relatively uncommon and few cases have been reported in detail. METHODS Here, we describe the molecular features of two cases of primary prostate cancer with MLH1 loss d